Data processing: financial – business practice – management – or co – Automated electrical financial or business practice or... – Health care management
Reexamination Certificate
2011-04-05
2011-04-05
O'Connor, Gerald J (Department: 3686)
Data processing: financial, business practice, management, or co
Automated electrical financial or business practice or...
Health care management
Reexamination Certificate
active
07921021
ABSTRACT:
A process, system, and manufacture are provided for decreasing the amount of treatment a patient requires from a first care-giver. In at least one example, the system comprises a means for receiving a set of records, and the set of records includes at least one representing a treatment prescribed by the first care-giver, and at least one representing at least one patient characteristic. There is also a means for determining, from the set of records, independently of records relating to effectiveness of the treatment prescribed for the patient, and based on a predetermined set of screening criteria, whether a different treatment is appropriate. Further, a means is provided for generating, based on the screening, an eligibility tag associated with the patient for providing notice to the patient associated with the eligibility tag of the different treatment availability at no cost to the patient and of a financial consequence of receipt of the treatment.
REFERENCES:
patent: 6338039 (2002-01-01), Lonski et al.
patent: 2002/0004725 (2002-01-01), Martin et al.
patent: 2002/0192159 (2002-12-01), Reitberg
patent: 2003/0120516 (2003-06-01), Perednia
patent: 2003/0144884 (2003-07-01), Mayaud
Joyce Kamanitz, Anthony Kotin, Norrie Thomas; Use of Pharmacy Claims Data to Improve Mental Health Disease Management; Drug Benefit Trends; p. 214, 215, 219, 221 and 222.
A Holistic Way to Cut Your Antidepressant Drug Costs; Managing Benefits Plans; Mar. 2006; p. 1-4; Issue 06-03; Institute of Management & Administration, Inc.; New York, U.S.
Nancy Ann Jeffrey, HMOs Seek Cures for Costly Psychosomatic Ills, The Wall Street Journal, Jul. 9, 1997, Section B1.
Craig Gunsauley, Prozac Nation: As anti-depressant utilization surges, PBMs promote various programs, Employee Benefit News, Mar. 1, 2002, vol. 16, No. 3.
Unknown, Stress Should Be Targeted in Assessments for Disease Risk, BenefitNews.com, Mar. 27, 2003.
Unknown, Ohio Insurer Offers Depression Management Program, BenefitNews.com, Aug. 12, 2003.
Unknown, Woman Say Depression Hampers Ability to Work, BenefitNews.com, Nov. 11, 2003.
Unknown, Let the Sun Shine in: Medication, Talk Therapy Solutions Offer Help, Hope to Depression Sufferers, BenefitNews.com, Dec. 22, 2003.
Sara Schaefer Munoz, Cost to Treat a Depression Case Falls, The Wall Street Journal, Dec. 31, 2003, Health & Family.
Unknown, Treatment Costs Down, Yet Depression Still Cost Drain, BenefitNews.com, Jan. 6, 2004.
Unknown, Month-long Campaign Targets Depression, Heart Disease, BenefitNews.com, Feb. 5, 2004.
Unknown, Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications, U.S. Food and Drug Administration, FDA Public Health Advisory, Mar. 22, 2004.
Unknown, Depressed Employees Underuse Mental Health Benefits, BenefitNews.com, Mar. 30, 2004.
Unknown, Employers Need to be Aware of Presenteeism's Cost, BenefitNews.com, Apr. 27, 2004.
Unknown, More Than a Quarter of Americans Treated for Mental Health, BenefitNews.com, May 6, 2004.
Unknown, Prescription Drug Use Soars Nationally, BenefitNews.com, Dec. 7, 2004.
David P. Steiner, Private Sector Needs Help to Rein in Health Care Costs, Houston Chronicle, Jan. 10, 2005.
Unknown, Companies Tackle Root Causes of Health Care Cost Increases, BenefitNews.com, May 24, 2005.
Barbara Martinez, Drug Co-Pays Hit $100 to Curb Rising Costs, Companies Try Range of Tactics to Push Employees to Cheaper Medicines, The Wall Street Journal, Jun. 28, 2005, D1.
Anna Wilde Mathews and Heather Won Tesoriero, FDA Moves Toward Harder Line on Suicide Risks, The Wall Street Journal, Jul. 1, 2005, B3.
Jennifer Corbett Dooren, FDA to Boost ADHD Drug Warnings, Dow Jones Newswires, Jul. 1, 2005, B3.
Leila Abboud, The Next Phase in Psychiatry, The Wall Street Journal, Jul. 27, 2005, D1.
Anna Wilde Mathews, Reading Fine Print, Insurers Question Studies of Drugs, The Wall Street Journal, Aug. 24, 2005, A1.
Leila Abboud, Generic Fares Well in Big Psychiatry Study, The Wall Street Journal, Sep. 20, 2005, D1.
Armstrong, David and Winstein, Keith J.; Antidepressants Under Scrutiny Over Efficacy; Reprinted from The Wall Street Journal, Jan. 17, 2008; 2 pages.
Brauer, Lisa PhD; Measurement-Based Outcome for Depression; Clinical Compass, Jan. 13, 2009, vol. 4, Issue 1, 3 pages.
Centers for Prevention and Health Services; An Employer's Guide to Behavioral Health Services, 14 pages.
Dooren, Jennifer Corbett; Effectiveness of Antidepressants Varies Widely; Reprinted from The Wall Street Journal, Jan. 6, 2010; 1 page.
Koster, Kathleen; Study finds antidepressants provide no cure for absenteeism; EmployeeBenefit news; Feb. 16, 2010, 1 page.
Wang, Shirley S.; Studies: Mental Ills Are Often Overtreated or Undertreated; Reprinted from The Wall Street Journal, Jan. 5, 2010; 1 page.
Wojcik, Joanne; Antidepressant monitoring falls short: Study; Business Insurance; Aug. 9, 2000; 1 page.
Department of Labor Request for Ruling: Pharmacy Intervention Protocol (patent pending), Interface EAP, 17 pages.
Letter from Cribbs Rizza, Elaine at The Rizza Group Professional Corporation regarding Total Life Assistance, Jul. 7, 2005, 3 pages.
Letter from Cribbs Rizza, Elaine at The Rizza Group Professional Corporation regarding Total Life Assistance, Apr. 26, 2006, 9 pages.
Letter from Hoffman, Michael at Arizona Benefit Plans, Inc. regarding Existing Large Employer utilizing the Pharmacy Intervention Protocol, Aug. 19, 2010, 1 page.
Fax from Mitchell, Heather at U.S. Department of Labor regarding rules of wellness program, Jun. 24, 2010, 4 pages.
Fax from Farrington, Christina at The Phia Group, LLC regarding comparison of wellness and pharmacy review program, Jul. 9, 2010, 3 pages.
Newman, Fred, Improving Treatment Outcomes through Drug Interventions, Journal of Employee Assistance, 2nd Quarter, 2010, 3 pages.
Case Study—Interface EAP's Pharmacy Intervention Protocol, 3 pages.
Arnold & Knobloch, L.L.P.
Interface EAP, Inc.
O'Connor Gerald J
Pauls John A
LandOfFree
System, method, and manufacture for decreasing the amount of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System, method, and manufacture for decreasing the amount of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System, method, and manufacture for decreasing the amount of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2687723